Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Deok-Hwan Yang, MD PhD, Jae-Sook Ahn, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Young Rok Do, PhDMD, Sang Yun Song, MD PhD, Ga-Young Song, Hyeong Jong Kim, MD, Theresa Kim

Blood (2019) 134 (Supplement_1): 2329.

https://doi.org/10.1182/blood-2019-126533

Published: 2019

Journal Articles

Rituximab-CHOP and Central Nervous System Prophylaxis Using Intrathecal Methotrexate in Primary Breast Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm Phase II Study

Ho-Young Yhim, MD, Cheolwon Suh, Seok Jin Kim, MD PhD, Deok-Hwan Yang, MD PhD, Hyeon-Seok Eom, MD, Kyoung Ha Kim, MD PhD, Yong Park, Jin Seok Kim, MD PhD, Hyo Jung Kim, MD PhD, Dok Hyun Yoon, MD PhD, Won Seog Kim, MD PhD, Jae-Yong Kwak, MD PhD

Blood (2019) 134 (Supplement_1): 4076.

https://doi.org/10.1182/blood-2019-122631

Published: 2019

Journal Articles

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Ga-Young Song, Seok Jin Kim, MD PhD, Sang Eun Yoon, Jin Seok Kim, MD PhD, Ho-Young Yhim, MD PhD, Youngil Koh, MD PhD, Sung Yong Oh, MD PhD, Ho Sup Lee, MD PhD, Ho-Jin Shin, MD PhD, Young Rok Do, MD PhD, Won Sik Lee, MD PhD, Lee Gyeong-Won, Dae Sik Kim, Yong Park, Deok-Hwan Yang, MD PhD

Blood (2019) 134 (Supplement_1): 4002.

https://doi.org/10.1182/blood-2019-126574

Published: 2019

Journal Articles

Clinical Impact of Enrollment of Clinical Trial in Multiple Myeloma; Single Center Experience

Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Ga-Young Song, Deok-Hwan Yang, MD PhD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2019) 134 (Supplement_1): 5525.

https://doi.org/10.1182/blood-2019-127889

Published: 2019

Journal Articles

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, MD PhD, Marc S. Tyndel, B. Eng, Seung-Shin Lee, MD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Ja-yeon Lee, MSc, Yoojin Lee, MDPhD, Sang Kyun Sohn, MD PhD, Zhaolei Zhang, PhD, Hyeoung-Joon Kim, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 2669.

https://doi.org/10.1182/blood-2018-99-112037

Published: 2018

Journal Articles

Diagnostic Accuracy of Immunoglobulin Heavy Chain Rearrangement, FDG-PET/CT and Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Diffuse Large B Cell Lymphoma

Seung-Yeon Jung, Sung-Hoon Jung, MD, Seo-Yeon Ahn, MD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Jun Hyung Lee, MD, Myung Geun Shin, MD PhD, Su Woong Yoo, Deok-Hwan Yang, MD PhD

Blood (2018) 132 (Supplement 1): 4236.

https://doi.org/10.1182/blood-2018-99-116398

Published: 2018

Journal Articles

Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas

Seo-Yeon Ahn, MD, Seung-Yeon Jung, Sung-Hoon Jung, MD, Jae-Sook Ahn, MD PhD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Sae-Ryung Kang, MD, Yeon-Hee Han, MD, Jae-Yong Kwak, MD PhD, Ho-Young Yhim, MD PhD, Deok-Hwan Yang, MD PhD

Blood (2018) 132 (Supplement 1): 1632.

https://doi.org/10.1182/blood-2018-99-118168

Published: 2018

Journal Articles

Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, Marc S. Tyndel, Yeo-Kyeoung Kim, Seung-Shin Lee, MD, Seo-Yeon Ahn, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Myung-Geun Shin, MD PhD, Hoon Kook, MD PhD, Sun-Hee Kim, MD, Seong Kyu Park, MD, Hyeoung-Joon Kim, Zhaolei Zhang, PhD, Dennis (Dong-Hwong) Kim, MD PhD

Blood (2017) 130 (Supplement 1): 271.

https://doi.org/10.1182/blood.V130.Suppl_1.271.271

Published: 2017

Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blood (2017) 130 (Supplement 1): 2840.

https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840

Published: 2017

Journal Articles

Blinatumomab Treatment in Korean Adult Patients with Relapse/Refractory Acute Lymphoblastic Leukemia

Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Jae-Ho Yoon, MD PhD, Seok Lee, MD PhD, Dae Sik Kim, MD PhD, Se Ryun Lee, MD PhD, Sung-Hyun Kim, MD PhD, Ji Hyun Lee, MD PhD, Soo-Mee Bang, MD PhD, Youngil Koh, MD, Ho-Young Yhim, MD, Sang Kyun Sohn, MDPhD, Ik-Chan Song, MD, Hong-ghi Lee, MD PhD, June-Won Cheong, MDPhD, Yunsuk Choi, MD, Ho-Jin Shin, MD PhD

Blood (2017) 130 (Supplement 1): 5004.

https://doi.org/10.1182/blood.V130.Suppl_1.5004.5004

Published: 2017

Journal Articles

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Blood (2017) 130 (Supplement 1): 5075.

https://doi.org/10.1182/blood.V130.Suppl_1.5075.5075

Published: 2017

Journal Articles

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, Marc S. Tyndel, Yeo-Kyeoung Kim, Seung-Shin Lee, MD, Seo-Yeon Ahn, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Yoojin Lee, MD, Sang Kyun Sohn, MDPhD, Yoo Hong Min, MD PhD, June-Won Cheong, MDPhD, Hyeoung-Joon Kim, Zhaolei Zhang, PhD, Dennis (Dong-Hwong) Kim, MD PhD

Blood (2017) 130 (Supplement 1): 3955.

https://doi.org/10.1182/blood.V130.Suppl_1.3955.3955

Published: 2017

Journal Articles

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Seo-Yeon Ahn, Seong Young Kwon, Young Rok Do, MD PhD, Sung-Hoon Jung, MD, Jae-Sook Ahn, Yeo-Kyeoung Kim, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, Su Woong Yoo, Jung-Joon Min, Deok-Hwan Yang, MD PhD

Blood (2017) 130 (Supplement 1): 1546.

https://doi.org/10.1182/blood.V130.Suppl_1.1546.1546

Published: 2017

Journal Articles

Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma

Sung-Hoon Jung, MD, Seo-Yeon Ahn, Seung-Shin Lee, MD, Jae-Sook Ahn, Deok-Hwan Yang, MD PhD, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 5456.

https://doi.org/10.1182/blood.V130.Suppl_1.5456.5456

Published: 2017

Journal Articles

Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements

Deok-Hwan Yang, MD PhD, Joon Ho Moon, MD, PhD, Seung-Shin Lee, MD, Jung-Joon Min, MD, Shin-Young Jeong, MD PhD, Yoo-Jin Lee, MD, Sung-Woo Park, MD, Yee Soo Chae, MD, Young Rok Do, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee

Blood (2015) 126 (23): 1446.

https://doi.org/10.1182/blood.V126.23.1446.1446

Published: 2015

Journal Articles

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Sung-Hoon Jung, MD PhD, Hee Kyung Kim, Seok Jin Kim, MD PhD, Seung-Shin Lee, MD, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, Kihyun Kim

Blood (2015) 126 (23): 5313.

https://doi.org/10.1182/blood.V126.23.5313.5313

Published: 2015

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

Generation of Potent Tumor-Specific CTLs from High-Dose IL-2 Activated naïve CD8 T Cells with Overcoming the Tumor-Derived Immune Suppression

Hong-Hanh Nguyen, Dong-hwan Kim, Hyun-Ju Lee, Sung-Hoon Jung, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD, Deok-Hwan Yang, MD PhD

Blood (2014) 124 (21): 4973.

https://doi.org/10.1182/blood.V124.21.4973.4973

Published: 2014

Journal Articles

Clinical Outcomes and Prognostic Factors of Front-Line Autologous Stem Cell Transplantation in Patients with Extranodal NK/T-Cell Lymphoma

Ho-Young Yhim, MD PhD, Jin Seok Kim, Yeung-Chul Mun, Chu-Myong Seong, Joon Ho Moon, Yong Park, MD PhD, Jae-Cheol Jo, MD, Seok Jin Kim, MD PhD, Jae-Yong Kwak, MD PhD, Je-Jung Lee, MD PhD, Deok-Hwan Yang, MD PhD

Blood (2014) 124 (21): 2523.

https://doi.org/10.1182/blood.V124.21.2523.2523

Published: 2014

Journal Articles

Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia

Yeo-Kyeoung Kim, MD, PhD, Sung-Hoon Chung, MD, PhD, Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Il-Kwon Lee, PhD, Nan-Young Kim, PhD, Li Yu, PhD, Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2013) 122 (21): 4758.

https://doi.org/10.1182/blood.V122.21.4758.4758

Published: 2013

NARROW

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Rituximab-CHOP and Central Nervous System Prophylaxis Using Intrathecal Methotrexate in Primary Breast Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm Phase II Study

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Clinical Impact of Enrollment of Clinical Trial in Multiple Myeloma; Single Center Experience

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Diagnostic Accuracy of Immunoglobulin Heavy Chain Rearrangement, FDG-PET/CT and Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Diffuse Large B Cell Lymphoma

Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas

Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blinatumomab Treatment in Korean Adult Patients with Relapse/Refractory Acute Lymphoblastic Leukemia

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma

Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Generation of Potent Tumor-Specific CTLs from High-Dose IL-2 Activated naïve CD8 T Cells with Overcoming the Tumor-Derived Immune Suppression

Clinical Outcomes and Prognostic Factors of Front-Line Autologous Stem Cell Transplantation in Patients with Extranodal NK/T-Cell Lymphoma

Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only